IVF Lab Billing Under a Separate Tax ID: A Complete Guide

A growing number of fertility practices operate their embryology laboratory as a legally and financially separate entity from the clinical practice — a different tax identification number (EIN), a different National Provider Identifier (NPI), and sometimes a different legal name on the insurance panel. This structure is common among large REI groups that separated the lab for liability, partner compensation, or CLIA compliance reasons, and among hospital-affiliated programs where the clinical and laboratory functions are housed in different cost centers. From a billing standpoint, the separation creates a parallel revenue stream that many practices manage poorly: lab claims filed without proper credentialing, CPT codes billed by the wrong entity, prior authorization obtained in the clinic's name but applied to lab claims, and denial patterns that nobody tracks because the two billing operations don't talk to each other. This guide explains how to set up and execute IVF lab billing under a separate tax ID correctly, from credentialing to claim submission to denial management.

Why Fertility Practices Separate the Embryology Lab

The decision to operate the embryology laboratory as a separate legal entity typically originates outside the billing department — in corporate structure, partnership agreements, or regulatory requirements — but its billing consequences are significant and largely unavoidable once the separation exists. The most common drivers are CLIA laboratory certification requirements, which treat the embryology lab as a distinct certified facility; malpractice liability isolation, which keeps embryology-related claims from reaching the clinical group's insurance policy; partner compensation arrangements where embryologist-partners are compensated through the lab entity rather than the clinical group; and hospital affiliation structures where a hospital system owns the clinical professional component and a separate physician-owned entity operates the laboratory. Regardless of the structural rationale, payers see the separate EIN as a separate billing entity. That entity must be credentialed independently, must obtain prior authorizations in its own name (or have the authorization scope explicitly cover its services), and must file claims that accurately reflect its NPI and tax ID — or face systematic denial on identity and authorization mismatch grounds.

CPT Codes That Belong to the Embryology Lab

The first question when a lab operates under a separate tax ID is which CPT codes the lab entity actually owns versus which remain with the clinical practice. The general rule is that codes requiring the physical presence of a laboratory facility and laboratory personnel — culture, fertilization, cryopreservation, embryo biopsy, thawing — belong to the lab. Codes requiring physician interpretation, diagnosis, or procedural performance in a clinical setting belong to the REI practice. The table below reflects the most common CPT code assignments in a split lab/clinic billing structure:

The distinction between lab codes and clinical codes is not always intuitive, and the industry's default assumption — that "IVF billing" means one entity bills everything — leads to persistent errors when the lab is separate. The retrieval (CPT 58976) and the transfer (CPT 58978) are physician procedures performed by the REI under sterile technique; they belong to the clinical practice. The culture (89250, 89272), fertilization (89268), ICSI (89280, 89281), and cryopreservation (89337, 89342) are laboratory services performed by embryologists; they belong to the lab entity. When both entities bill for the same patient on the same cycle, payers with coordination of benefits edits will often flag the combined claim for review. The claims need to be internally consistent in date of service, diagnosis code, and procedure sequence — but they are filed separately, under different tax IDs, against the same authorization if the authorization covers both service types.

Credentialing the Lab as a Separate Billing Entity

Before a separate lab entity can be paid by any payer, it must be independently credentialed — enrolled in the payer's network or registered as a non-participating provider in states where non-par billing applies. This is the single most common error in practices that transition to a split-entity billing structure: the clinic has been on panel with every payer for years, but the lab entity has never been credentialed because nobody thought to do it. The result is a backlog of denied lab claims, all adjudicated under the "provider not enrolled" or "invalid billing provider" denial codes, that requires months of retro-credentialing and resubmission to recover.

• Obtain a separate Group NPI for the lab entity — the lab's organizational NPI is distinct from any individual embryologist NPIs and from the clinical group's organizational NPI
• Enroll the lab entity in CAQH ProView separately from the clinical practice; CAQH profiles are linked to NPI, and many payers pull credentialing data directly from CAQH
• Apply for network participation with every commercial payer that already covers the clinic's patients, submitting the lab's EIN, Group NPI, CLIA certificate number, and service address — which may differ from the clinical address if the lab is at a different physical location
• Track credentialing timelines separately; a lab entity credentialing application typically takes 90 to 180 days at large payers — plan for a gap period during which lab services may need to be bundled under the clinical group to avoid service interruption
• Confirm that payer contracts explicitly cover laboratory services; some fertility-specific contracts are written to cover REI professional services only and require a separate contract amendment to cover the lab entity's technical services
• For fertility benefit managers (Progyny, WINFertility, Carrot), verify whether they credential labs separately or require the clinic to bundle lab billing through the clinical group NPI — Progyny in particular has specific guidelines on this that vary by employer group contract
• Obtain a CLIA certificate for the lab entity if it does not already have one; filing claims for high-complexity lab services without an active CLIA certificate is a compliance violation independent of the billing structure

Prior Authorization When the Lab Has a Different Tax ID

Prior authorization for IVF creates a structural problem when the lab is a separate entity: most payers issue a single authorization for "IVF" that covers the overall treatment cycle but does not enumerate each individual service type or specify which billing entity may apply the authorization. In a single-entity practice, this is not a problem. When the clinic and lab are separate tax IDs, the authorization obtained by the clinical group may not be accepted on a claim filed by the lab, because payers match authorization numbers to the billing provider NPI on the claim — and if the lab NPI was not included in the authorization request, some payers will deny the lab claim as "unauthorized service" even though the cycle itself was authorized.

The practical workflow for authorization in a split-entity structure requires coordination between whoever manages the clinic's prior authorizations and whoever manages the lab's billing. In many practices, these are different people or different billing companies. A standard protocol should require: (1) the authorization coordinator at the clinic to list the lab's Group NPI on every IVF authorization request; (2) the authorization number to be shared with the lab billing team before the cycle begins; (3) the lab to include the authorization number in Box 23 of the CMS-1500 (or EDI loop 2300 REF*G1) on every claim filed under the lab's NPI; and (4) a post-submission verification confirming that the payer accepted the authorization number on the lab claim before the claim moves to adjudication. This coordination does not happen by default — it requires written policy and regular communication between both billing operations.

How to File Claims Under the Separate Lab Tax ID

Lab claims filed under a separate EIN are structured on the CMS-1500 (or its electronic EDI 837P equivalent) with the lab entity in the billing provider position — Box 33 on the CMS-1500, which contains the billing provider name, address, and NPI — and the lab's EIN in Box 25. The treating physician in Box 31 is typically the REI who ordered or supervised the laboratory services, using the physician's individual NPI. The service facility in Box 32, if different from the billing address, identifies the physical lab location. When the lab is at the same address as the clinical practice, Box 32 may be left blank at some payers, but if the payer requires facility-level identification, populate it with the lab's address and NPI regardless.

Date of service discipline is critical for lab claims and more complex than it appears. The date of service for culture codes (89250, 89272) is the date the culture was initiated — which is the day after oocyte retrieval, not the date the embryos were transferred or the date the cycle concluded. The date of service for ICSI (89280, 89281) is the day the insemination procedure was performed in the lab — again, typically the day following retrieval. The date of service for embryo biopsy (89290, 89291) is the date the biopsy was physically performed. For cryopreservation of oocytes (89337) or embryos after a fresh IVF cycle, the date of service is the day vitrification was performed. Filing all lab services under the retrieval date or the transfer date — a common shortcut — creates date-of-service inconsistencies that auditors flag and that payers use as grounds for denial when claim dates do not align with the clinical record.

ICD-10 Code Alignment Between Clinic and Lab Claims

Both the clinical entity and the lab entity must use consistent ICD-10 diagnosis codes for the same patient and cycle. Payers that cross-reference claims across billing entities for the same patient will flag a cycle where the clinical claim was filed with N97.0 (Female infertility associated with anovulation) as the primary diagnosis, but the lab claim for the same cycle used Z31.83 (Encounter for assisted reproductive fertility procedure cycle), without a connecting secondary code. This does not automatically produce a denial, but it creates a discrepancy in the payer's system that can trigger a medical records request or flag the claim for manual review.

The recommended approach is to standardize diagnosis code sets across both entities at the cycle level. The clinical entity's ICD-10 codes — primary infertility diagnosis, any secondary conditions such as N80.0 for endometriosis or E28.2 for polycystic ovarian syndrome — should be shared with the lab billing team when the cycle begins, so that the lab's claims include the same primary and secondary diagnosis codes where applicable. Z31.83 should appear on both entities' claims as the procedure encounter code when the cycle is an active ART cycle. Consistency prevents cross-entity discrepancies and reduces the likelihood of a payer audit triggered by mismatched diagnosis coding across two claims from the same treatment episode.

Payer-Specific Rules for Split-Entity Lab Billing

Not all payers handle split-entity fertility billing the same way, and the policies that govern how lab claims are processed vary by plan type, whether a fertility benefit manager is involved, and whether the payer's contract was negotiated with awareness of the split structure. The following covers the most commonly encountered payer-specific rules for lab entities:

• Progyny: Requires that practices using Progyny Smart Cycles bill through the contracted clinic NPI. If the lab is a separate entity not separately contracted with Progyny, it cannot file claims to Progyny independently. Practices in this situation must either negotiate a separate lab contract with Progyny or bill all lab services through the clinic's Progyny contract — confirm the permissible billing structure with your Progyny practice liaison before assuming either approach is acceptable
• WINFertility: Will pay lab claims separately if the lab is enrolled as a WINFertility provider, but requires timely filing from the lab entity independently of the clinical claim. The lab's timely filing window runs from the date of service on the lab claim, not from the date the clinical claim was submitted — missing WINFertility's timely filing deadline is one of the most common and least-recoverable denial reasons for separate-entity lab claims
• Aetna: Under most Aetna fertility benefit plans, laboratory services are covered but require that the lab be an in-network provider separately enrolled with Aetna. An out-of-network lab filing claims against an Aetna plan where the patient has in-network-only coverage will be denied — and the non-participating lab cannot balance-bill in states with surprise billing protections when the service was referred by the patient's in-network REI
• Cigna: Cigna fertility plans often require global billing in which the clinic bundles the lab's technical component charges with the clinical claim, even when the lab operates under a separate EIN. If your clinic is subject to a Cigna global billing requirement, the lab's revenue must be settled internally between the two entities, not through separate claims to Cigna. Confirm whether your Cigna contract contains a global billing clause before establishing separate lab claims submission
• United Healthcare: UHC allows separate lab billing when the lab is credentialed and contracted, but applies coordination of benefits logic across the clinical and lab claims for the same cycle. If the combined payments from both claims exceed the allowed amount for the cycle under the UHC fee schedule, UHC may recoup the overage from the lab claim as the secondary payer in the cycle billing sequence
• Blue Cross Blue Shield: BCBS rules vary dramatically by state plan. BCBS of Illinois requires separate credentialing for lab entities and will pay both entities separately. Some BCBS plans in non-mandate states deny lab claims entirely from entities not on the fee schedule for laboratory services, irrespective of the lab's credentialing status in other lines of business
• Self-funded employer plans: When the payer is a self-funded employer plan administered by a TPA, the plan document governs whether lab services are a covered benefit. Many self-funded plans are silent on embryology laboratory services specifically — meaning coverage is interpreted by the TPA claims adjudicator, which can produce inconsistent results. If lab claims from your entity are repeatedly denied by a self-funded plan that pays the clinical claims, request the plan's summary plan description and coverage criteria for "laboratory" services and build an appeal around the specific lab CPT codes that qualify as covered laboratory procedures

Common Denials for Separate Lab Entity Claims and How to Prevent Them

Internal Coordination Between Clinic and Lab Billing Operations

When billing is split across two entities — whether managed by two in-house billing teams or two different billing companies — the operational risk is not technical. It is communication. Payers do not care that your clinic and lab are separate legal entities; they care that claims submitted on behalf of their members are accurate, authorized, and internally consistent. Achieving that consistency when two billing teams are working independently requires formal coordination protocols that many practices treat as optional and then learn are essential after a wave of preventable denials.

• Cycle notification protocol: the clinic's billing team or scheduling team should send a cycle-start notification to the lab billing team at the time the patient's IVF cycle is activated in the EHR, including patient demographics, insurance information, authorization number, and expected cycle components — so the lab billing team has the information needed to bill before the cycle concludes
• Shared charge master alignment: the clinic and lab should reconcile their internal charge description masters annually to confirm that code assignments are consistent — no code appears on both entities' CDMs for the same service, and every billable lab service has a charge code on the lab's CDM
• Monthly cross-entity denial reconciliation: billing leaders from both entities should review denial reports together monthly, specifically looking for denials that indicate cross-entity errors (duplicate billing, authorization mismatches, NPI conflicts) — these patterns are invisible if each entity only reviews its own denials in isolation
• Shared authorization log: maintain a centralized log accessible to both billing teams that records every authorization number, the entities it covers, the services it authorizes, and its expiration date — so neither team submits a claim against an expired or entity-restricted authorization without knowing it
• Payer contract library: ensure both billing teams have access to the contract terms for every payer that covers patients at the practice, with annotations identifying which terms apply specifically to lab billing (global billing clauses, lab credentialing requirements, separate timely filing windows)

Revenue Impact of Getting Split-Entity Lab Billing Right

The financial stakes for a separate-entity embryology lab are substantial. A mid-size IVF program performing 500 cycles per year with a split lab structure has a lab revenue stream that may represent 20 to 35 percent of total cycle revenue — ICSI, culture, biopsy, cryopreservation, and thawing charges collectively add up to several thousand dollars per cycle at negotiated rates. At 500 cycles per year, a lab billing operation with a 15 percent denial rate that goes unmanaged — denials that expire, timely filing windows that close, authorization mismatches that no one appeals — is leaving $150,000 to $400,000 annually on the table depending on payer mix and lab fee schedule rates. That is not a rounding error; it is an organizational decision made by neglect.

Practices that invest in credentialing the lab entity correctly, establishing cross-entity coordination protocols, and building lab-specific denial management workflows consistently outperform those that treat lab billing as a secondary concern managed by whoever has time. The lab's CPT codes are not complex. The authorization and credentialing requirements are not ambiguous once you understand them. The payer-specific rules, while varied, are learnable and documentable. What separates a lab billing operation that recovers 92 percent of charges from one that recovers 70 percent is not technical expertise — it is operational discipline applied consistently to a service line that generates real revenue and deserves the same systematic attention as the clinic's professional billing.

If your practice recently separated its lab into a distinct legal entity — or is considering doing so — the billing transition plan should begin six months before the first claim is filed under the new EIN. That timeline allows for credentialing applications to process at major payers, for authorization workflows to be updated to include the lab NPI, for both billing teams (or your billing company) to train on the split-entity claim structure, and for a parallel billing test period during which lab claims are verified in the payer's system before the go-live date. Skipping this transition planning and filing under the new EIN on day one of the entity change is one of the most reliable ways to generate a backlog of uncorrectable denials that requires months of manual work to resolve.